Diane Baniewicz

机构：Children's Hospital of Philadelphia

发表论文 32 篇 · 总被引 1329 次 · h-index 16

代表论文

• Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial (2021 · Journal of Clinical Oncology · 被引 213)
• Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (2021 · Journal of Clinical Oncology · 被引 191)
• Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia (2018 · Blood · 被引 158)
• CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials (2021 · The Lancet Haematology · 被引 122)
• Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy (2021 · Blood · 被引 117)
• The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL). (2017 · Journal of Clinical Oncology · 被引 97)